Assess whether regulatory approval is a timing risk or a deal risk after IT
August 31, 2026
SITUATION Commercial-diligence partner at a family-office reviewing a manufacturing target is reviewing post-merger systems-integration risk register after IT diligence showing two ERPs and no chart of accounts map. The question on that extract is whether regulatory approval is a timing risk or a deal risk. The packet does not yet prove Regulatory approval is a timing risk versus A deal risk.
DECISION Commercial-diligence partner in a family-office reviewing a manufacturing target must choose Regulatory approval is a timing risk / A deal risk using post-merger systems-integration risk register after IT diligence showing two ERPs and no chart of accounts map.
HYPOTHESES TO TEST 1. The population in post-merger systems-integration risk register is the one IT diligence showing two ERPs and no chart of accounts map named, so Regulatory approval is a timing risk follows for this Earnings and Revenue Quality file. 2. The population in post-merger systems-integration risk register is adjacent only to IT diligence showing two ERPs and no chart of accounts map; A deal risk is the honest M&A Due Diligence call. 3. A family-office reviewing a manufacturing target already contained IT diligence showing two ERPs and no chart of accounts map before post-merger systems-integration risk register arrived; no new Earnings and Revenue Quality path. 4. Provenance on post-merger systems-integration risk register after IT diligence showing two ERPs and no chart of accounts map is broken; do not pick Regulatory approval is a timing risk or A deal risk yet.
ANALYSIS REQUIRED 1. Name the document commercial-diligence partner still needs before signing. 2. Test whether IT diligence showing two ERPs and no chart of accounts map is a diligence gap, a price chip, or a walk-away. 3. Separate a one-off add-back from a recurring earnings issue in post-merger systems-integration risk register. 4. For this M&A Due Diligence Earnings and Revenue Quality file, read post-merger systems-integration risk register against IT diligence showing two ERPs and no chart of accounts map and write the one fact that would move regulatory approval is a for commercial-diligence partner.
RECOMMENDATION Choose Regulatory approval is a timing risk / A deal risk on this M&A Due Diligence / Earnings and Revenue Quality packet (post-merger systems-integration risk register after IT diligence showing two ERPs and no chart of accounts map). If post-merger systems-integration risk register cannot force a M&A Due Diligence label under Earnings and Revenue Quality, stop. Do not invent missing evidence a family-office reviewing a manufacturing target does not have.
COMMAND RETURNS - Bottom-line M&A Due Diligence option on regulatory approval is a, then the evidence in post-merger systems-integration risk register, then the action for commercial-diligence partner - Hypothesis scorecard against post-merger systems-integration risk register: supported / rejected / untestable - What changes regulatory approval is a if IT diligence showing two ERPs and no chart of accounts map is later withdrawn - Named option among Regulatory approval is a timing risk, A deal risk and the fact that kills the others
Explore more
More M&A Due Diligence prompts
- Assess whether to re-trade, restructure, or drop from IP ownership vs
- Assess whether related-party sales should be backed out of valuation (13cbd9)
- IP diligence counsel's financial counterpart must resolve whether regulatory
- Whether environmental liability is capped or open-ended from management-team
- Whether integration costs were sandbagged in the CIM from management-team
Explore related decision areas
- Assess whether CAT pricing is defensible given SOV quality (58d912)Insurance Underwriting
- Assess whether product recall exposure is priced or excluded (dcee52)Insurance Underwriting
- Assess whether a warranty should be converted to a condition precedentInsurance Underwriting
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

